BTS
IONS icon

BB&T Securities’s Ionis Pharmaceuticals IONS Stock Holding History

BB&T Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$572K Sell
9,561
-1,983
-17% -$129K 0.01% 1046
2019
Q2 		$741K Buy
11,544
+379
+3% +$26.8K 0.01% 940
2019
Q1 		$906K Sell
11,165
-993
-8% -$64.1K 0.01% 838
2018
Q4 		$657K Sell
12,158
-252
-2% -$12.9K 0.01% 879
2018
Q3 		$640K Sell
12,410
-1,234
-9% -$58K 0.01% 979
2018
Q2 		$568K Sell
13,644
-3,559
-21% -$158K 0.01% 1019
2018
Q1 		$758K Sell
17,203
-2,350
-12% -$119K 0.01% 876
2017
Q4 		$983K Sell
19,553
-702
-3% -$38.5K 0.01% 755
2017
Q3 		$1.03M Sell
20,255
-800
-4% -$41.9K 0.01% 735
2017
Q2 		$1.07M Buy
21,055
+4,173
+25% +$194K 0.02% 716
2017
Q1 		$678K Buy
16,882
+4,532
+37% +$204K 0.01% 786
2016
Q4 		$452K Hold
12,350
– – 0.01% 867
2016
Q3 		$452K Buy
12,350
+606
+5% +$19K 0.01% 867
2016
Q2 		$273K Buy
11,744
+1,843
+19% +$59.5K ﹤0.01% 1023
2016
Q1 		$400K Buy
9,901
+3,762
+61% +$153K 0.01% 843
2015
Q4 		$380K Sell
6,139
-216
-3% -$11.7K 0.01% 828
2015
Q3 		$256K Sell
6,355
-211
-3% -$10.9K 0.01% 921
2015
Q2 		$377K Buy
6,566
+278
+4% +$17.7K 0.01% 826
2015
Q1 		$400K Buy
6,288
+1,035
+20% +$70.2K 0.01% 795
2014
Q4 		$324K Buy
+5,253
New +$259K 0.01% 862

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BB&T Securities's IONS Position: Q3 2019 in Review

BB&T Securities reduced its Ionis Pharmaceuticals (IONS) stake by 17% in Q3 2019, selling an estimated $129K and leaving 9,561 shares worth $572K. The position accounts for 0.01% of the portfolio, ranked #1046.

BB&T Securities first reported a position in IONS in Q4 2014 and has held it in 20 quarters since. The position peaked at $1.07M in Q2 2017. 370 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

  • BB&T Securities held 9,561 shares of Ionis Pharmaceuticals worth $572K as of Q3 2019.
  • BB&T Securities sold 1,983 Ionis Pharmaceuticals shares in Q3 2019, an estimated $129K.
  • Ionis Pharmaceuticals made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #1046 holding.
  • BB&T Securities first reported a position in Ionis Pharmaceuticals in Q4 2014 and has held it in 20 quarters since.
  • BB&T Securities's Ionis Pharmaceuticals position peaked at $1.07M in Q2 2017.
  • 370 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.